Nav: Home

Study shows bilingual lupus support and education program has positive impact

November 14, 2016

A bilingual support group addressing the psychological and educational needs of patients with lupus and their families is a valuable resource to help them cope, according to a study at Hospital for Special Surgery (HSS).

The research, "Evaluating the Charla de Lupus (Lupus Chat)® Program's Teen, Young Adult and Parent Support Group: Reaching the Hispanic/Latino Community through a Family Model of Support" was presented at the American College of Rheumatology/Association of Rheumatology Health Professionals annual meeting on November 13 in Washington, DC.

"Lupus is a chronic autoimmune illness that not only affects a person medically, but also mentally and emotionally," said Melissa Flores, MPH, LMSW, program coordinator of Charla in the Department of Social Work Programs at Hospital for Special Surgery. "People with lupus may experience debilitating symptoms such as extreme fatigue, joint pain, and skin rashes. Additionally, there are often psychosocial challenges, such as feelings of isolation, adjusting to medications with difficult side effects, and coping with the invisible, unpredictable nature of the illness."

Research shows that chronic illnesses such as lupus have a wide-ranging impact on the family. HSS started Charla to offer help and strategies to patients and their loved ones for managing the disease. "Lupus disproportionately affects women of color," Flores explains. "Our program strives to address health disparities by serving African American and Hispanic/Latino communities through our family model of support and our bilingual/bicultural programming."

The free monthly, hospital-based program provides support and education to teens and young adults under age 30, as well as their loved ones. Conducted in English and Spanish, each two-hour session consists of a presentation by an expert on a subject of interest to patients, a workshop or an open discussion. Topics include medications, nutrition, research and doctor-patient communication.

Flores and colleagues set out to determine how much the sessions helped participants and their families, with particular interest in the impact on Hispanic/Latino group members. A 16-item survey in English and Spanish was distributed after seven group meetings between 2015 and 2016.

A total of 148 surveys were handed out, including questions on overall satisfaction, knowledge, coping and disease management. Separate analyses were conducted for teens and young adults versus their parents/caregivers. Responses were also classified by ethnicity.

A total of 141 surveys were returned, which represented 95% of those who had received the questionnaire. Fifty percent of the respondents were teens/young adults and half were family members. Seventy-three percent were female. More than half of the respondents (68%) were Hispanic/Latino, 29% were African American, 28% were another race, 23% were White and 13% were Asian.

The answers to open-ended questions showed substantial improvements in knowledge and coping strategies in areas such as explaining lupus to others and communicating with doctors.

Additional survey results:
  • 99% of all respondents reported overall satisfaction with the program
  • 94% agreed that the program increased their knowledge of lupus-related issues
  • 88% agreed that the groups helped them to cope
  • 90% agreed that they could apply what they had learned to manage lupus
  • 95% agreed that the program met their expectations
  • 98% agreed that the presenter was clear and informative
  • 96% agreed that they would recommend the program

While overall ratings were high, the survey indicated that the meetings were particularly beneficial to Hispanics/Latinos. A higher percentage of Hispanics/Latinos indicated that the program increased their knowledge of lupus, helped them with disease management and coping, and met their expectations.

"Our results demonstrate the value of the group and our success in engaging patients with lupus. The evaluation also underscores the relevance of the family model of support when serving a diverse group of chronically ill teens and young adults and their caregivers," Flores said.
-end-
Study Title: "Evaluating the Charla De Lupus (Lupus Chat)® Program's Teen, Young Adult and Parent Support Group: Reaching the Hispanic/Latino Community through a Family Model of Support"

Authors: Melissa T. Flores1, Jillian A. Rose2, Priscilla Toral1, Roberta Horton1, Dariana M. Pichardo1, Lillian Mendez1 and Lisa F. Imundo3, 1Social Work Programs, Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, New York, NY, 3Assoociate Professor of Pediatrics in Medicine - Rheumatology, Columbia University Medical Center, New York, NY



About Hospital for Special Surgery


Hospital for Special Surgery (HSS) is the world's largest academic medical center focused on musculoskeletal health. HSS is nationally ranked No. 1 in orthopedics and No. 2 in rheumatology by U.S. News & World Report (2016-2017), and is the first hospital in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. HSS has one of the lowest infection rates in the country. HSS is an affiliate of Weill Cornell Medical College and as such all Hospital for Special Surgery medical staff are faculty of Weill Cornell. The hospital's research division is internationally recognized as a leader in the investigation of musculoskeletal and autoimmune diseases. Hospital for Special Surgery is located in New York City and online at http://www.hss.edu.

Hospital for Special Surgery

Related Lupus Articles:

Systemic lupus erythematosus (SLE)
If renal remission is achieved therapeutically in cases of lupus nephritis (LN), the 10-year survival rate increases significantly.
Race-specific lupus nephritis biomarkers
A University of Houston biomedical researcher has discovered a difference in urinary biomarker proteins of lupus nephritis in patients according to race.
Lupus patients who take their medications lower their diabetes risk
Patients with lupus who take their medications as prescribed have much lower odds of developing type 2 diabetes, a common complication of the disease, finds a new study from the University of British Columbia.
Nearly 1 in 3 patients with lupus use prescription opioids for pain
A new study finds nearly one in three adults with lupus use prescription opioids to manage pain, despite a lack of evidence that opioids are effective for reducing pain from rheumatic diseases.
Developing therapeutic strategies for pregnant women with lupus
A highly gender-biased disease, lupus afflicts females some nine times more than males.
Lupus antibody target identified
Researchers have identified a specific target of antibodies that are implicated in the neuropsychiatric symptoms of lupus, according to human research published in JNeurosci.
B cells off rails early in lupus
Emory scientists could discern that in people with SLE, signals driving expansion and activation are present at an earlier stage of B cell differentiation than previously appreciated.
Can adverse childhood experiences worsen lupus symptoms?
Adverse childhood experiences (ACEs) encompass traumas such as abuse, neglect, and household challenges.
Unlocking the female bias in lupus
The majority of lupus patients are female, and new findings from the University of Pennsylvania shed light on why.
How a single faulty gene can lead to lupus
IBS-AIM (Academy of Immunology and Microbiology) research team at Pohang University of Science and Technology (POSTECH) in South Korea has discovered the role of a key gene involved in the autoimmune disease systemic lupus erythematosus (SLE) or lupus for short.
More Lupus News and Lupus Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Warped Reality
False information on the internet makes it harder and harder to know what's true, and the consequences have been devastating. This hour, TED speakers explore ideas around technology and deception. Guests include law professor Danielle Citron, journalist Andrew Marantz, and computer scientist Joy Buolamwini.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

How to Win Friends and Influence Baboons
Baboon troops. We all know they're hierarchical. There's the big brutish alpha male who rules with a hairy iron fist, and then there's everybody else. Which is what Meg Crofoot thought too, before she used GPS collars to track the movements of a troop of baboons for a whole month. What she and her team learned from this data gave them a whole new understanding of baboon troop dynamics, and, moment to moment, who really has the power.  This episode was reported and produced by Annie McEwen. Support Radiolab by becoming a member today at Radiolab.org/donate.